An inhibitory effects of interleukin-1a on basal gonadotropin release in the ovariectomized rhesus monkey: reversal by a corticotropin-releasing factor antagonist
- PMID: 1900786
- DOI: 10.1210/endo-128-4-2077
An inhibitory effects of interleukin-1a on basal gonadotropin release in the ovariectomized rhesus monkey: reversal by a corticotropin-releasing factor antagonist
Abstract
Interleukin-1 (IL-1), an important component of the immune system, has recently been shown to influence the release of several hormones in the rodent. In this paper, the effectiveness of IL-1a in modulating basal gonadotropin secretion as well as cortisol release in the primate has been investigated. Eight adult ovariectomized rhesus monkeys were given a 30-min intracerebroventricular infusion of physiological saline (n = 5), various doses of IL-1a (17 micrograms n = 5; 8.5 micrograms; n = 3; 4.2 micrograms n = 5; and 2.1 micrograms n = 4) or IL-1a plus a CRF antagonist (n = 5). LH and FSH concentrations were measured at 15-min intervals during the 3-h preinfusion baseline control and the 5-h postinfusion period, while cortisol concentrations were determined at 45-min intervals. While LH concentrations remained unchanged in the monkeys receiving saline only, they decreased significantly after the 30-min IL-1a infusion. By hour 5 after IL-1a administration, mean (+/- SE) hourly areas under the LH curves (expressed as a percentage of preinfusion baseline) were 27.7% +/- 7.3 (17 micrograms IL-1a), 31.9% +/- 8.4 (8.5 micrograms), 33.3% +/- 5.5 (4.2 micrograms), and 39% +/- 4.0 (2.1 micrograms) (P less than 0.05 vs. morning control). FSH concentrations were also significantly decreased after IL-1a, 17 micrograms: by hour 5, they were 67.4% +/- 5.0 of baseline control. While cortisol concentrations decreased thoughout the experiment in the animals receiving saline, they increased with all IL-1a doses: overall mean (+/- SE) postinfusion concentrations were 21.8 +/- 1.1 (saline), 49.5 +/- 2.2 (IL-1a, 17 micrograms), 35.1 +/- 1.9 (8.5 micrograms), 45.7 +/- 1.5 (4.2 micrograms), and 39.5 +/- 1.5 (2.1 micrograms) micrograms/dl (P less than 0.05 IL-1a vs. saline). Concomitant infusion of the CRF antagonist, [D-Phe12, NLE 21,38caMe LEU37] CRF (12-41), (120-360 micrograms), prevented the IL-1a induced LH inhibition. By hour 5, areas under LH curves were 33.5% +/- 1.7 for IL-1a alone and 99.2% +/- 4.2 (NS vs. saline) for IL-1a + CRF antagonist. The CRF antagonist also blocked the ability of IL-1a to increase cortisol secretion: mean cortisol concentrations were 28.6 +/- 1.4 micrograms/dl (NS vs. saline). The results clearly indicate that the cytokine IL-1a inhibits pulsatile LH and FSH secretion in the ovariectomized rhesus monkey and demonstrate that this inhibition is causally related to the activation of CRF by this cytokine.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Vasopressin mediates the interleukin-1 alpha-induced decrease in luteinizing hormone secretion in the ovariectomized rhesus monkey.Endocrinology. 1992 Jul;131(1):153-8. doi: 10.1210/endo.131.1.1611995. Endocrinology. 1992. PMID: 1611995
-
Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.Endocrinology. 1987 Sep;121(3):837-42. doi: 10.1210/endo-121-3-837. Endocrinology. 1987. PMID: 3113919
-
Stimulatory effects of interleukin-induced activation of the hypothalamo-pituitary-adrenal axis on gonadotropin secretion in ovariectomized monkeys replaced with estradiol.Endocrinology. 1994 Nov;135(5):2093-8. doi: 10.1210/endo.135.5.7956932. Endocrinology. 1994. PMID: 7956932
-
Alpha-melanocyte-stimulating hormone antagonizes the neuroendocrine effects of corticotropin-releasing factor and interleukin-1 alpha in the primate.Endocrinology. 1992 Jul;131(1):132-8. doi: 10.1210/endo.131.1.1319315. Endocrinology. 1992. PMID: 1319315
-
A role for the endogenous opioid peptides in the regulation of gonadotropin secretion in the primate.Horm Res. 1987;28(2-4):119-25. doi: 10.1159/000180935. Horm Res. 1987. PMID: 3136066 Review.
Cited by
-
Astressin B, a nonselective corticotropin-releasing hormone receptor antagonist, prevents the inhibitory effect of ghrelin on luteinizing hormone pulse frequency in the ovariectomized rhesus monkey.Endocrinology. 2008 Mar;149(3):869-74. doi: 10.1210/en.2007-1350. Epub 2007 Dec 6. Endocrinology. 2008. PMID: 18063681 Free PMC article.
-
Impact of Severity of Illness on the Function of the Hypothalamo-pituitary-gonadal Axis in Postmenopausal Women with Acute Severe Illness: Implications for Predicting Disease Outcome.Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):738-744. doi: 10.4103/ijem.IJEM_398_16. Indian J Endocrinol Metab. 2017. PMID: 28989885 Free PMC article.
-
Neonatal lipopolysaccharide exposure exacerbates stress-induced suppression of luteinizing hormone pulse frequency in adulthood.Endocrinology. 2007 Dec;148(12):5984-90. doi: 10.1210/en.2007-0710. Epub 2007 Sep 13. Endocrinology. 2007. PMID: 17872370 Free PMC article.
-
Evaluation of activity of hypothalamo-pituitary-gonadal axis in postmenopausal women suffering from severe acute illness.Indian J Med Res. 2016 Jan;143(1):66-71. doi: 10.4103/0971-5916.178596. Indian J Med Res. 2016. PMID: 26997016 Free PMC article.
-
Signaling pathways and promoter regions that mediate pituitary adenylate cyclase activating polypeptide (PACAP) self-regulation in gonadotrophs.Mol Cell Endocrinol. 2020 Jul 15;512:110851. doi: 10.1016/j.mce.2020.110851. Epub 2020 May 18. Mol Cell Endocrinol. 2020. PMID: 32439415 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous